FDA Approves Agile Therapeutics, Inc.’s Twirla (levonorgestrel and ethinyl estradiol) Transdermal System – A New Weekly Contraceptive Patch Delivering a 30 mcg Daily Dose of Estrogen and 120 mcg Daily Dose of Progestin

Posted in Biotech

February 14, 2020 • 2 min read

PRINCETON, N.J., Feb. 14, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq: AGRX) (Agile or the Company), a forward-thinking women’s healthcare company, today announced that the U.S. Food and Drug Administration (FDA) has approved Twirla...

Onconova Therapeutics Stock Flying on Anticipated Data

Posted in Biotech

February 11, 2020 • 2 min read

Onconova Therapeutics' stock (NASDAQ:ONTX) is on a tear in the last week, jumping over 90% on the anticipated company update being presented in February 17 at Noble Capital Markets’ Sixteenth Annual Investor Conference....

Aerpio Pharmaceuticals Presents Data from Fifth Patient Cohort Showing Potential of Topical Ocular Formulation of AKB-9778 Product Candidate When Combined with Prostaglandin in Subjects with Primary Open Angle Glaucoma or Ocular Hypertension

Posted in Biotech

February 07, 2020 • 2 min read

Aerpio Pharmaceuticals, Inc. (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, announced that Kevin Peters, M.D., Aerpio’s Chief Scientific Officer, pre...